Disease, Diagnoses, and Dollars - ISBN: 9780387740454 - (ebook) - von Robert M. Kaplan, Verlag: Copernicus - Details - OvW eBook Shop

Details

Disease, Diagnoses, and Dollars

Facing the Ever-Expanding Market for Medical Care

von: Robert M. Kaplan

19,99 €

Verlag: Copernicus
Format: PDF
Veröffentl.: 21.04.2009
ISBN/EAN: 9780387740454
Sprache: englisch
Anzahl Seiten: 190

DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.

Beschreibungen

Here’s a conundrum: the U.S. health care system is the largest sector in the biggest economy in the world, and the US spends significantly more per capita on health care than any other country. Yet it ranks last among comparison nations on the major health indicators. Robert Kaplan attempts to tackle these anomalies head-on by taking the controversial position that mass markets have been created for services that may offer little or no benefit to patients. Kaplan forcefully argues that the overuse of medications and tests runs up the costs of health care, and offers potential solutions for policy makers and for patients.
The US spends more per capita on health care than any other country, yet it ranks last among comparison nations on the major health indicators. Here, Kaplan analyzes what can be done to turn this situation around and provides useful advice to policymakers.
Disease, Diagnoses, and Dollars is about the costs of health care and their impact on health. The U.S. health care system is the largest sector in the biggest economy, and the US spends significantly more per capita on health care than any other country, yet it ranks last among comparison nations on the major health indicators. Within the U.S., there is evidence that regions that spend more do not have better outcomes, and some evidence suggests that quality of care is lower in the regions that spend more, not less, on health care.
Robert Kaplan takes the controversial position that mass markets have been created for services that may offer little or no benefit to patients. Many of these markets are for preventive medicine, making healthy people a market for expensive pharmaceutical products and tests. These include cancer screening tests and medications to control blood pressure, cholesterol, and glucose. Kaplan forcefully argues that the overuse of medications and tests runs up the costs of health care. As more employers drop health insurance for their employees when costs accelerate, the expanded use of ineffective preventive medicine may have the unintended consequence of increasing the number of uninsured patients, potentially damaging the health of others in the community.
The concluding chapters of Disease, Diagnoses, and Dollars offer suggestions for policy makers and for patients. Methods for systematically evaluating the cost-effectiveness of new guidelines are discussed. The final chapter provides practical suggestions to enable patients to share in decisions about treatments or tests that can have uncertain benefits.
Disease, Outcomes, and Money.- The Disease-Reservoir Hypothesis.- Mental Models of Health and Healthcare.- What Is Disease and When Does It Begin?.- Screening for Cancer.- Deciding When Blood Pressure Is Too High.- The Cholesterol Cutoff.- Diabetes, Obesity, and the Metabolic Syndrome.- Cost-Effectiveness and Opportunity Costs.- Shared Medical Decision-Making.- Putting the Pieces Together.
Robert M. Kaplan is Professor and Chair of the Department of Health Services at the UCLA School of Public Health. He is also a Professor of Medicine at the UCLA David Geffen School of Medicine. He has been elected president of four different academic societies and has served as editor-in-chief for two major journals. Kaplan is the author or editor of 16 books and more than 400 articles or chapters. In 2005, he was elected to the Institute of Medicine of the National Academies of Science.
Disease, Diagnoses, and Dollars
Facing the Ever-Expanding Market for Medical Care

Robert M. Kaplan, UCLA School of Public Health, Los Angeles, CA

Close to 50 Million Uninsured,
Steeply Rising Insurance Premiums,
Employers Cutting Healthcare Benefits . . .

There’s plenty wrong with this picture. In Disease, Diagnoses, and Dollars, public health expert Robert Kaplan takes America’s healthcare industry to task and challenges readers to examine their own roles in it.

Provocative, timely, and comprehensively researched, this book analyzes the current healthcare crisis in terms of medical culture, economics, and advertising. The findings reveal a system fraught with conflicts—contradictory healthcare policies, providers who over-test and over-prescribe, patients with unrealistic demands fueled by the media—and throughout, an absence of accountability. Much of preventive medicine, Kaplan persuasively argues, comes down to the selling of expensive pills and procedures that drive up costs while subjecting the population to unneeded risks and complications. And the end result, he argues, is excess care for many people, and a dearth of care for many more.

Kaplan’s informed, practical, and constructive approach makes Disease, Diagnoses, and Dollars a "must-read" volume for policymakers and professionals in public health and healthcare, and for business owners as well as ordinary citizens and consumers concerned with the viability of healthcare in America.
Controversial as it questions the foundations of preventive medicine
Timely criticism of the health care industry and the costs of health care
Challenges established definitions of disease, specifically in cancer, cholesterol, diabetes, obesity
Disease, Diagnoses, and Dollars is about the costs of health care and their impact on health. The book provides a timely criticism of the health care industry and the costs of health care. Within the U.S. health care system, there is evidence that regions that spend more do not have better outcomes, and some evidence suggests that quality of care is lower in the regions that spend more, not less, on health care. The author takes the controversial position that mass markets have been created for services that may offer little or no benefit to patients. He forcefully argues that the overuse of medications and tests runs up the costs of health care. The concluding chapters offer suggestions for policy makers and for patients. Methods for systematically evaluating the cost-effectiveness of new guidelines are discussed. The final chapter provides practical suggestions to enable patients to share in decisions about treatments or tests that can have uncertain benefits.

Diese Produkte könnten Sie auch interessieren:

MedRevolution
MedRevolution
von: Boris Bogdan
PDF ebook
14,99 €
Manualdiagnostik - Assessment Fruchtwasser
Manualdiagnostik - Assessment Fruchtwasser
von: Kirstin Astrid Hähnlein
EPUB ebook
80,00 €
Vaccines: Are they Worth a Shot?
Vaccines: Are they Worth a Shot?
von: Andrea Grignolio
PDF ebook
23,79 €